Kenvue Inc. (KVUE), the consumer health giant behind brands like Tylenol, Listerine, and Neutrogena, reported a slight decline in third-quarter sales but saw an improvement in profitability. The company’s adjusted gross profit margin expanded due to efficiency gains and pricing strategies, while volume decline was mainly driven by Skin Health and Beauty and Self Care segments.
Kenvue Inc. (KVUE), the parent company of popular brands like Listerine, Mylanta, and Tylenol, is showing strong bullish signals. The stock is approaching a Golden Cross, a technical indicator suggesting potential for a significant price increase. A recent legal victory regarding Tylenol ‘Rapid Release’ gelcaps further strengthens the company’s position.
